• Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page

Layoffs


<







Sigh. How many were cut from eye division?

If you include cutting the contract salesforce they slaughtered about two thirds. Three reps in a territory to one rep, about cut the managers in half, same with the RDs (six to two plus one for inside sales), took out inside sales people too, and rumor is they hit some home office folks as well. The cuts were massive. Abbvie knows it's about to hit the fan with all the LOEs.
 




If you include cutting the contract salesforce they slaughtered about two thirds. Three reps in a territory to one rep, about cut the managers in half, same with the RDs (six to two plus one for inside sales), took out inside sales people too, and rumor is they hit some home office folks as well. The cuts were massive. Abbvie knows it's about to hit the fan with all the LOEs.
Yeah it was brutal.
 
















Word on the Street 50%? Please someone confirm or deny. Which is next? Derm? WH? GIC?
Pretty sure CNS, 1 vraylar rep to every 3 doctors....and the Migraine will be next....Just too much overlap with not enough drug...may not happen until after the indication launch for CNS but that will be greeted with yeah so what...always have used it that way...etc. Good luck Pharma is dying...Spent a long long long long time in it and it was a good ride, but what it has become particularly with the pushing of programs and activities ....never be the same
 




Similar threads

Replies
34
Views
13K
AbbVie
anonymous
Replies
18
Views
5K
AbbVie
anonymous
Replies
21
Views
13K
AbbVie
anonymous
Replies
31
Views
12K
AbbVie
anonymous
Replies
17
Views
6K
AbbVie
anonymous